Aspergillosis of the temporomandibular joint following irradiation of the parotid region: a case report.
We report a case of aspergillosis in the right temporomandibular joint (TMJ) with a history of parotid carcinoma and post-irradiation otitis. Previous treatment attempts with surgery and antibiotics were unsuccessful. Radical debridement of the glenoid fossae, supplemented with amphotericin B and adjunct hyperbaric oxygen (HBO) therapy, was provided to resolve the symptoms. This case report highlights the need to be aware of the possibility of invasive mycosis in immunocompromised patients.
Lo
W L
WL
Oral and Maxillofacial Surgery, Department of Dentistry, Taipei-Veterans General Hospital, National Yang-Ming University, School of Dentistry, Taipei, Taiwan, ROC.
Chang
R C S
RC
Yang
A H
AH
Kao
S Y
SY
D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D006801:Humans; D006931:Hyperbaric Oxygenation; D008297:Male; D010025:Osteoradionecrosis / Q000382:microbiology* / Q000473:pathology / Q000628:therapy; D010307:Parotid Neoplasms / Q000532:radiotherapy; D011878:Radiotherapy / Q000009:adverse effects; D013704:Temporomandibular Joint / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D013705:Temporomandibular Joint Disorders / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D016896:Treatment Outcome
D000935:Antifungal Agents; D000666:Amphotericin B